What trends in NCSM's EPS suggest for 2025 investments?

NCS Multistage Holdings, Inc. (NCSM) does not appear to have any reported EPS data for the fiscal quarter ending Q1 2025. However, we can infer certain trends and implications for 2025 investments based on the available data.

1. **Recent Performance**: NCSM's recent performance has been strong, with a reported 28% year-over-year increase in total revenues for Q4 2024, reaching $45.0 million. This growth was driven by a significant rise in international revenues, with strength in the Middle East tracer diagnostics projects and Canada showing strong year-over-year growth of 19.5%.
2. **International Expansion**: The company's focus on international expansion has been a key driver of growth, with international revenues more than doubling and now accounting for over 10% of total revenue. This trend suggests that NCSM may continue to benefit from its global operations in 2025.
3. **Financial Metrics**: NCSM reported a robust revenue increase for 2024, with a 14% increase in revenue, reaching over $160 million. The company maintained a strong gross margin of approximately 40% and had a positive net cash position of $17.7 million at the end of 2024. These financial metrics indicate a strong financial performance and cash conversion, which could support investments in the company.
4. **Market Challenges**: Despite the positive trends, NCSM faces potential challenges, such as the strengthening of the US dollar relative to the Canadian dollar, which negatively impacted its revenue and adjusted EBITDA guidance for 2025. Additionally, the company anticipates flat to down customer activity in the United States for 2025, which could affect overall revenue growth.
5. **Investment Considerations**: Based on the available data, NCSM's strong revenue growth, improved margins, and international expansion suggest a positive outlook for investments in 2025. However, investors should be aware of the potential challenges and market conditions that could impact the company's performance. It is recommended to closely monitor the company's progress in international markets and any developments regarding the US dollar's strengthening trend.

In conclusion, while there are no specific EPS data available for Q1 2025, the trends in NCSM's recent performance, international expansion, and financial metrics suggest a positive outlook for investments in 2025. However, investors should consider the potential challenges and market conditions that could impact the company's performance.